Are there pulmonary sequelae in patients recovering from COVID-19?

Autor: Angelo Coppola, Ermanno Puxeddu, Dejanira D'Amato, Gianluigi Sergiacomi, Luigino Calzetta, Antonio Orlacchio, Paola Rogliani
Rok vydání: 2020
Předmět:
Male
Hospitalized patients
Thoracic
Pulmonary Fibrosis
Severe Acute Respiratory Syndrome
Gastroenterology
Cohort Studies
Hospitals
University
0302 clinical medicine
Pulmonary fibrosis
Viral
Prospective Studies
030212 general & internal medicine
Prospective cohort study
Letter to the Editor
Middle Aged
Combined Modality Therapy
Hospitals
Hospitalization
Italy
Disease Progression
Female
Radiography
Thoracic
Coronavirus Infections
Cohort study
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pneumonia
Viral
Risk Assessment
03 medical and health sciences
Settore MED/36
Internal medicine
Hounsfield scale
Confidence Intervals
medicine
Humans
In patient
Pandemics
Aged
lcsh:RC705-779
University
business.industry
COVID-19
lcsh:Diseases of the respiratory system
Pneumonia
medicine.disease
Radiography
030228 respiratory system
HRCT
business
Follow-Up Studies
Zdroj: Respiratory Research
Respiratory Research, Vol 21, Iss 1, Pp 1-4 (2020)
ISSN: 1465-993X
DOI: 10.1186/s12931-020-01550-6
Popis: It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to fibrotic sequelae in patients recovering from coronavirus disease 2019 (COVID-19). In this observational study, hospitalized patients with COVID-19 had a HRCT of the chest performed to detect the extension of fibrotic abnormalities via Hounsfield Units (HU). At follow-up, the lung density significantly improved in both lungs and in each lobe of all patients, being in the normal range (− 950 to − 700 HU). This study provides preliminary evidence that hospitalized patients with mild-to-moderate forms of COVID-19 are not at risk of developing pulmonary fibrosis.
Databáze: OpenAIRE
Externí odkaz: